C. Bolm et al.
tr(R)=17.7 min (Chiralcel OG, flow rate 1.0 mLminꢀ1, heptane/iPrOH
95:5, l=230 nm, 208C).
[1] a) C. Liang, F. R. Peillard, C. Fruit, P. Mꢃller, R. H. Dodd, P.
[2] a) D. Leca, A. Toussaint, C. Mareau, L. Fensterbank, E. Lacꢄte, M.
4505; c) C. Fruit, F. Robert-Peillard, G. Bernardinelli, P. Mꢃller,
[4] C. Worch, C. Bolm, Synthesis 2007, 1355–1358.
[5] C. Worch, C. Bolm, Synthesis 2008, 739–742.
[6] S. Azzaro, L. Fensterbank, E. Lacꢄte, M. Malacria, Synlett 2008,
2253–2256.
[7] For early studies of sulfonimidamides, see: a) E. S. Levchenko, N. Y.
Derkach, A. V. Kirsanov, Zh. Obshch. Khim. 1962, 32, 1208–1212;
[8] For interesting bioactive sulfonimidamide derivatives, see: a) C. L.
Hillemann (Du Pont), US Patent 4666506, 1987; b) J. E. Toth, G. B.
Grindey, W. J. Ehlhardt, J. E. Ray, G. B. Boder, J. R. Bewley, K. K.
Klingerman, S. B. Gates, S. M. Rinzel, R. M. Schultz, L. C. Weir, J. F.
(S)-N-(4-Tolylsulfinyl)-benzamide (5): Same procedure as described for
4, but use of benzoic anhydride (6.18 mmol, 1.40 g) instead of di-tert-
butyl dicarbonate. The product was recrystallized from hexane/ethyl ace-
tate (2/1, 30 mL) and (S)-N-(4-tolylsulfinyl)-benzamide (5) was isolated
in colorless crystals (814 mg, 3.14 mmol, 61%, >99% ee). M.p. 121–
1228C; [a]2D0 =+118 (c=1.0 in CHCl3); 1H NMR (300 MHz, CDCl3): d=
2.43 (s, 3H, CH3), 7.31–7.36 (m, 2H, Ar-H), 7.40–7.47 (m, 2H, Ar-H),
7.52–7.59 (m, 1H, Ar-H), 7.61–7.66 (m, 2H, Ar-H), 7.79–7.84 (m, 2H,
Ar-H), 8.56 ppm (s, 1H, NH); 13C NMR (75 MHz, CDCl3): d=21.5
(CH3), 124.8 (2CH), 127.9 (2CH), 128.8 (2CH), 130.1 (2CH), 131.6 (C),
133.1 (CH), 140.7 (C), 142.6 (C), 167.3 ppm (CO); IR (KBr): n˜ = 720,
756, 807, 883, 1069, 1095, 1244, 1387, 1648, 3225 cmꢀ1; MS (EI, 70 eV):
m/z (%): 259 (19) [M+], 151 (2), 139 (33), 108 (50), 105 (100), 91 (22); el-
emental analysis calcd (%) for C14H13NO2S: C 64.84, H 5.05, N 5.40;
found: C 65.10, H 5.31, N 5.45; HPLC: tr(R)=24.9 min, tr(S)=33.0 min
(Chiralcel OD-H, flow rate 1.0 mLminꢀ1
, heptane/iPrOH 95:5, l=
230 nm, 208C).
(S)-N-tert-Butyloxycarbonyl-4-toluenesulfonimidamide (8): A solution of
(S)-tert-Butyl-(4-tolylsulfinyl)-carbamate (4) (850 mg, 3.33 mmol) in THF
(25 mL) was cooled to 08C, and tert-butyl hypochlorite (4.33 mmol,
470 mg, 0.489 mL) was then slowly added. The reaction was stirred at
08C for 1 h. At 08C an aqueous ammonia solution (25%, 13.3 mL) was
added and the reaction mixture was stirred a room temperature over-
night. After neutralization of the reaction mixture by addition of a 6m
HCl solution, the organic layer was separated and the aqueous phase was
extracted with dichloromethane (4ꢂ20 mL). The combined organic
layers were dried (MgSO4), filtered and the solvent was removed under
reduced pressure. (S)-N-tert-Butyloxycarbonyl-4-toluenesulfonimidamide
(8) was isolated as a white powder (703 mg, 2.60 mmol, 78%, >99% ee).
M.p. 123–1248C; [a]2D0 =+14.5 (c=1.0 in CHCl3); 1H NMR (400 MHz,
CDCl3): d=1.37 (s, 9H, CH3), 2.43 (s, 9H, CH3), 5.85 (brs, 2H, NH2),
7.29–7.33 (m, 2H, Ar-H), 7.85–7.89 ppm (m, 2H, Ar-H); 13C NMR
(100 MHz, CDCl3): d=21.6 (CH3), 28.1 (3CH3), 80.6 (C), 127.1 (2CH),
129.6 (2CH), 137.8 (C), 144.0 (C), 157.1 ppm (CO); IR (KBr): n˜ = 697,
739, 799, 849, 952, 1120, 1154, 1238, 1311, 1623, 3280 cmꢀ1; MS (EI,
70 eV): m/z (%): 271 (1) [M+H]+, 215 (7), 197 (35), 171 (7), 154 (24),
139 (6), 108 (100), 91 (27); elemental analysis calcd (%) for
C12H18N2O3S: C 53.31, H 6.71, N 10.36; found: C 53.32, H 6.66, N 10.40;
HPLC: tr(R)=17.3 min, tr(S)=22.4 min (Chiralcel OD, flow rate
1.0 mLminꢀ1, heptane/iPrOH 90:10, l=254 nm, 208C).
b) G. Solladiꢅ, Synthesis 1981, 185–196; c) C. Mioskowski, G. Solla-
[10] F. A. Davis, Y. Zhang, Y. Andemichael, T. Fang, D. L. Fanelli, H.
[11] B. J. Backes, D. R. Dragoli, J. A. Ellman, J. Org. Chem. 1999, 64,
5471–5478.
[12] M. J. Mintz, C. Walling, Org. Synth. 1973, 5, 184–187.
[13] For related sulfinamides it was shown that the oxidative chlorination
using tert-butyl hypochlorite proceeds with retention of configura-
[14] For oxidative chlorinations of sulfinamides with N-chlorosuccin-
imide, where the stereochemical path remained undetermined, see:
[15] The Monte–Carlo method used in our calculations is based on a
standard simulated annealing algorithm with a temperature ramp of
(S)-N-Benzoyl-4-toluenesulfonimidamide (9): Same procedure as for the
synthesis of 8, but use of (S)-N-(4-tolylsulfinyl)-benzamide (5) (800 mg,
3.08 mmol) in THF (50 mL), tert-butyl hypochlorite (4.01 mmol, 435 mg,
0.454 mL) and an aqueous ammonia solution (25%, 12.4 mL). (S)-N-
Benzoyl-4-toluenesulfonimidamide (9) was isolated as a white powder
(822 mg, 3.00 mmol, 97%, >99% ee). M.p. 137–1398C; [a]2D0 =+64.2 (c=
0.9 in CHCl3); 1H NMR (400 MHz, [D6]acetone): d=2.41 (s, 3H, CH3),
7.23 (brs, 2H, NH2), 7.38–7.43 (m, 4H, Ar-H), 7.48–7.53 (m, 1H, Ar-H),
7.91–7.95 (m, 2H, Ar-H), 8.05–8.09 ppm (m, 2H, Ar-H); 13C NMR
(100 MHz, [D6]acetone): d=22.4 (CH3), 128.5 (2CH), 129.6 (2CH), 130.7
(2CH), 131.1 (2CH), 133.4 (CH), 138.2 (C), 141.6 (C), 145.2 (C),
173.4 ppm (CO); IR (KBr): n˜ = 716, 806, 838, 980, 1152, 1217, 1298,
1324, 1449, 1573, 1600, 3288 cmꢀ1; MS (EI, 70 eV): m/z (%): 275 (1) [M+
H]+, 197 (4), 154 (1), 139 (4), 108 (100), 91 (17); elemental analysis calcd
(%) for C14H14N2O2S: C 61.29, H 5.14, N 10.21; found: C 61.31, H 5.22, N
9.89; HPLC: tr(R)=37.1 min, tr(S)=55.8 min (Chiralcel OJ, flow rate
0.7 mLminꢀ1, heptane/iPrOH 85:15, l=230 nm, 208C).
T=TfꢀDT
ACHTUNGTRENNUNG
and T are the initial, final and the current temperature. I and Imax
represent the current step number and the maximal number of
steps. Imax depends on the number of flexible centres of the studied
molecule as well as the number of increments in the rotation. Final-
ly, the new conformation is weighted via the Boltzmann criteria.
[16] Spartan, Version 02, Wavefunction, Inc. 18401 Von Karman Ave.,
Suite 370, Irvine, CA 92612.
[18] Gaussian 03, Revision D.02, M. J. Frisch, G. W. Trucks, H. B. Schle-
gel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgom-
ery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S.
Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani,
N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K.
Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda,
O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian,
J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E.
Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W.
Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J.
Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C.
Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari,
J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cio-
slowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaro-
Acknowledgements
This work was supported by the Deutsche Forschungsgemeinschaft
(DFG, SPP 1179) and the Fonds der Chemischen Industrie.
682
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 677 – 683